ArticleBone marrow transplantation2020

Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment.

Hujun Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.